The diagnostic role of Next Generation Sequencing in uncovering isolated splenomegaly: A case report

Hematol Rep. 2021 Jun 21;13(2):8814. doi: 10.4081/hr.2021.8814. eCollection 2021 Jun 9.

Abstract

Many diseases can induce splenomegaly, however, about 5% of splenomegalies are idiopathic. When there is no underlying treatable cause, and the splenomegaly significantly affects the quality of life, splenectomy is the best therapeutic choice. A 67-year-old woman had idiopathic and asymptomatic splenomegaly. The increase in splenomegaly resulted in hypersplenism with cytopenia and symptoms related to abdominal discomfort. The patient underwent splenectomy which led to clinical improvement. A histological examination showed the presence of hematopoietic tissue. Peripheral blood Next Generation Sequencing with the myeloid panel SOPHiA Genetics showed the following mutations: ASXL1, SRSF2, KRAS and TET2. Three out of these four mutations were also found in the splenic tissue. Next Generation Sequencing could be useful in the diagnosis of splenomegalies associated with myeloproliferative neoplasms otherwise defined as idiopathic, in order to address a therapeutic strategy.

Keywords: Myeloproliferative Neoplasms; Next Generation Sequencing; Splenomegaly.

Grants and funding

Funding: None.